PCNA and neoplasm: Furthermore, findings from an in situ tumor model demonstrated that epirubicin effectively reduced the proliferation of U87-derived tumor tissues in situ (Fig. 7L), as well as downregulating the expression of KI67, PCNA, and GPX4 in the tissues (Fig. 7M).